Diabetes Management in the Hospital

Medical Clinics of North America

Volumn 92, Issue 2, 2008, Pages 407-425

  Donner, Thomas W ^a   Flammer, Kristin M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ASPARTAME; EXENDIN 4; GLUCOCORTICOID; GLUCOSE; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; PREDNISONE; SITAGLIPTIN; SULFONYLUREA;

BLOATING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EMERGENCY CARE; ENTERIC FEEDING; FLATULENCE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; MONOTHERAPY; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TOTAL PARENTERAL NUTRITION; UNSPECIFIED SIDE EFFECT;

DIABETES MELLITUS; HOSPITALISTS; HUMANS; INPATIENTS; OUTCOME ASSESSMENT (HEALTH CARE); UNITED STATES;

EID: 39649122638     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.10.001     Document Type: Review

References (58)

1. Cowie C.C., Rust K.F., Byrd-Holt D.D., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
3. Shichiri M., Kishikawa H., Ohkubo Y., et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl 2 (2000) B21-B29
4. U.K. Prospective Diabetes Study Group: intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837-853
5. The DCCT/EDIC Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
6. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Diabetes Care 29 (2006) 1955-1962
7. Clement S., Braithwaite S.S., Magee M.F., et al. The American Diabetes Association Diabetes in Hospitals Writing Committee: management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 (2004) 553-591
8. Garber A.J., Moghissi E.S., Bransome Jr. E.D., et al. The American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10 Suppl 2 (2004) 4-9
9. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
10. Malmberg K. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 (1997) 1512-1515
11. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
12. Levetan C.S., Passaro M., Jablonski K., et al. Unrecognized diabetes among hospitalized patients. Diabetes Care 21 (1998) 246-249
13. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87 (2002) 978-982
14. Hogan P., Dall T., Nikolov P., et al. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
15. Wexler D.J., Meigs J.B., Cagliero E., et al. Prevalence of hyper- and hypoglycemia among inpatients with diabetes. Diabetes Care 30 2 (2007) 367-368
16. Bagdade J.D., Steward M., and Walters E. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 27 (1978) 677-681
17. Alexiewicz J., Kumar D., Smogorzewski M., et al. Polymorphonuclear leukocytes in non-insulin dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123 (1995) 919-924
18. Repine J.E., Clawson C.C., and Goetz F.C. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J Infect Dis 142 (1980) 869
19. Ortmeyer J., and Mohsenin V. Inhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils. Life Sci 59 (1996) 255-262
20. Von Kanel R., Mills P., and Dimsdale J. Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci 69 (2001) 225-262
21. Bouter K.P., Meyling F.H., Hoekstra J.B., et al. Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus. Diabetes Res Clin Pract 19 (1992) 77-80
22. Morohoshi M., Fujisawa K., Uchimura I., et al. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45 (1996) 954-959
23. Pandolfi A., Giaccari A., Cilli C., et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plaminogen activator inhibitor type 1 in the rat. Acta Diabetol 38 (2001) 71-77
24. Knobler H., Savion N., Shenkman B., et al. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 90 (1998) 181-190
25. Giugliano D., Marfella R., Coppola L., et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95 (1997) 1783-1790
26. Estrada C.A., Young J.A., Nifong L.W., et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 75 (2003) 1392-1399
27. Furnary A.P., Wu Y., and Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10 Suppl 2 (2004) 21-33
28. Krinsley J.S. Effect of intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
29. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
30. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63 (1997) 356-361
31. Bolk J., van der Ploeg T., Cornel J.H., et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 207-214
32. Parsons M.W., Barber A., Desmond P.M., et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol 52 1 (2002) 20-28
33. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
34. Inzucchi S.E. Management of hyperglycemia in the hospital setting. N Engl J Med 355 (2006) 1903-1911
35. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 30 Suppl 1 (2007) S27-S31
36. Queale W.S., Siedler A.J., and Brancati F.L. Glycemic control and sliding scan insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157 (1997) 545-552
37. Gearhart J.G., Duncan III J.L., Replogle W.H., et al. Efficacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 14 (1994) 313-322
38. Hirsch I.B., Braithwaite S.S., and Verderese C.A. Practical management of inpatient hyperglycemia (2005), Hilliard Publishing LLC, Lakeville (CT)
39. Miller C., Phillips L., Ziemer D., et al. Hypoglycemia in patients with type 2 diabetes. Arch Intern Med 161 (2001) 1653-1659
40. Drucker D.J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26 (2003) 2929-2940
41. Leahy J.L. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract 12 Suppl 3 (2006) 86-90
42. Moghissi E.S., and Hirsch I.B. Hospital management of diabetes. Endocrinol Metab Clin North Am 34 (2005) 99-116
43. Abourizk N., Vora C., and Verma P. Inpatient diabetology: the new frontier. J Gen Intern Med 19 (2004) 466-471
44. DeSantis A.J., Schmeltz L.R., Schmidt K., et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 12 (2006) 491-505
45. Walsh J., Roberts R., Bailey T., et al. Using insulin: everything you need to know for success with insulin (2003), Torrey Pines press, San Diego (CA)
46. Markovitz L., Wiechmann R., Harris N., et al. Description and evaluation of a glycemic management protocol for diabetic patients undergoing heart surgery. Endocr Pract 8 (2002) 10-18
47. Moghissi E. Inpatient diabetes. Cleve Clin J Med 71 (2004) 801-808
48. Quevedo S.F., Sullivan E., Kington R., et al. Improving diabetes care in the hospital using guideline-directed orders. Diabetes Spectrum 14 (2001) 226-233
49. Donaldson S., Villanuueva G., Rondinelli L., et al. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients. Elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 32 6 (2006) 954-962
50. Tomky D. Detection, prevention, and treatment of hypoglycemia in the hospital. Diabetes Spectrum 18 (2005) 39-44
51. Bode B.W., Braithwaite S.S., Steed R.D., et al. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin. Endocr Pract 10 Suppl 2 (2004) 71-80
52. Trence D. Management of patients on chronic glucocorticoid therapy: an endocrine perspective. Primary Care: Clinics in Office Practice 30 (2003) 593-605
53. Hirsch I.B., and Paauw D.S. Diabetes management in special situations. Endocrinol Metab Clin North Am 26 3 (1997) 631-645
54. Luther P., and Baldwin D. Pioglitazone in the management of diabetes mellitus after transplantation. Am J Transplant 4 (2004) 2135-2138
55. Willis S.M., Kennedy A., Brant B.P., et al. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes. Diabetes Res Clin Pract 58 (2002) 87-96
56. Putz D., and Kabadi U.M. Insulin glargine in continuous enteric tube feeding. Diabetes Care 25 (2002) 1889-1890
57. Park R.H., Hansell D.T., Davidson L.E., et al. Management of diabetic patients requiring nutritional support. Nutrition 8 (1992) 316-320
58. Greci L.S., Kailasam M., Malkani S., et al. Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 26 (2003) 1064-1068